{"pub": "breitbart", "url": "https://breitbart.com/news/bayer-reports-surge-in-number-of-legal-cases-over-roundup", "downloaded_at": "2019-10-30 07:54:44.802642+00:00", "title": "Bayer reports surge in number of legal cases over Roundup", "language": "en", "text": "Frankfurt am Main (AFP) \u2013 German chemical and pharmaceutical giant Bayer reported Wednesday the number of US legal cases targeting it over weedkiller Roundup has more than doubled over the past three months, to 42,700.\n\nThe group blamed the explosive growth on massive spending on TV advertising by lawyers seeking new plaintiffs over controversial active ingredient glyphosate, with the figure for October up from 18,400 in July.\n\nBayer\u2019s ever-mounting wave of lawsuits in the US follows its takeover of seeds and pesticides maker Monsanto last year for $63 billion, one of the largest foreign acquisitions in German corporate history.\n\nA court-appointed mediator between Bayer and US plaintiffs in August denied reports the company had offered an $8 billion settlement to get the cases off its back.\n\nJuries in several lower courts granted plaintiffs massive damages awards over Roundup, although they were later reduced by judges and Bayer vowed to appeal \u2014 saying the weight of scientific evidence is against glyphosate causing cancer when used appropriately.\n\nAlso Wednesday, Bayer reported a 63.9-percent year-on-year plunge in third-quarter net profit, to 1.04 billion euros ($1.15 billion).\n\nThe group blamed the tumble on the comparison with last year\u2019s third quarter, which saw a massive windfall from businesses competition watchdogs forced it to sell in exchange for their green light to the Monsanto deal.\n\nIn operating, or underlying profits counting out such one-off effects, Bayer saw growth of 2.8 percent, to 1.23 billion euros.\n\nMeanwhile revenues grew 6.1 percent, to 9.83 billion euros.\n\nThe third quarter was marked by Bayer\u2019s deal to sell its veterinary medicines unit to US-based Elanco Animal Health for $7.6 billion, while it will also hand two flagship over-the-counter medicines brands \u2014 Dr Scholl\u2019s and Coppertone \u2014 to American and German buyers.", "description": "Frankfurt am Main (AFP) \u2013 German chemical and pharmaceutical giant Bayer reported Wednesday the number of US legal cases targeting it over", "authors": [], "top_image": "https://media.breitbart.com/media/2019/10/wi/afp/30/5bb611_juries-granted-plaintiffs-massive-damages-awards-roundup-bayer-reports-640x335.jpg", "published_at": "2019-10-30"}